Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Treating infections with ceftolozane/tazobactam in subjects having impaired renal function

US Patent 10933053 · Granted Mar 2, 2021

Estimated economic value: $166,587,000

Assignee

Inventors

View full patent text on Google Patents →